{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:24:01Z","timestamp":1780633441394,"version":"3.54.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Rep."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>The aim of this study was to evaluate the added diagnostic value of additional second stage pelvic scanning as part of the [<jats:sup>18<\/jats:sup>F]DCFPYL PET\/CT procedure in patients treated for prostate cancer (PCa) who have biochemical recurrence (BR).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods<\/jats:title>\n            <jats:p>Consecutive patients with a diagnosis of PCa who underwent a dual-phase PSMA-PET scan between September 2022 and December 2023, were retrospectively included. We analyzed the number and maximum SUV (SUVmax) of lesions only in the pelvic region (prostate, locoregional lymph nodes and bone), based on PSMA-RADS version 2.0 and miTNM criteria. To assess the potential diagnostic benefit of additional delayed pelvic PET\/CT imaging as part of the PSMA-PET procedure, the change in molecular TNM classification was evaluated after the procedure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Additional delayed pelvic PET\/CT imaging as part of the PSMA-PET procedure resulted in a change in molecular TNM classification in 22 out of 136 patients (16.2%). The highest percentage change was obtained in the miN classification (14\/22 patients), followed by the miT classification (7\/22) and lastly miM (1\/22). Moreover, we found that patients in whom delayed pelvic imaging resulted in a change in molecular TNM classification were significantly older and had a higher PSA level than those in whom delayed imaging did not provide additional information.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Pelvic delayed imaging in patients with biochemical recurrence of prostate cancer undergoing PET\/CT with [<jats:sup>18<\/jats:sup>F]DCFPYL shows a non-negligible influence on patient staging, modifying the miTNM classification in 16.2% of cases, with pelvic lymphatic involvement benefiting the most from the dual study.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41824-025-00238-8","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T23:02:50Z","timestamp":1738364570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of delayed pelvic imaging on the staging of biochemical recurrence in prostate cancer patients using [18F]DCFPYL PET\/CT: a retrospective evaluation"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1219-1847","authenticated-orcid":false,"given":"Ana","family":"Rodr\u00edguez-Pajuelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Guerra-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Ignacio","family":"Cuenca Cuenca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Freire-Mac\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Jim\u00e9nez-Hoyuela Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Mar\u00eda","family":"\u00c1lvarez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,1]]},"reference":[{"issue":"5","key":"238_CR15","doi-asserted-by":"publisher","first-page":"750","DOI":"10.2967\/jnumed.116.183483","volume":"58","author":"A Afshar-Oromieh","year":"2017","unstructured":"Afshar-Oromieh A, Sattler LP, Mier W, Hadaschik BA, Debus J, Holland-Letz T et al (2017) The clinical impact of additional late PET\/CT imaging with. J Nucl Med 58(5):750\u2013755","journal-title":"J Nucl Med"},{"issue":"9","key":"238_CR11","first-page":"1252","volume":"62","author":"I Alberts","year":"2021","unstructured":"Alberts I, Niklas-H\u00fcnermund J, Sachpekidis C, Zacho HD, Mingels C, Dijkstra L, Bohn KP, L\u00e4ppchen T, Gourni E, Rominger A, Afshar-Oromieh A (2021) Combination of forced diuresis with additional late imaging in. Eff Lesion Visibility Radiotracer Uptake J NuclMed 62(9):1252\u20131257","journal-title":"Eff Lesion Visibility Radiotracer Uptake J NuclMed"},{"issue":"5","key":"238_CR6","first-page":"3343","volume":"33","author":"M Bauckneht","year":"2023","unstructured":"Bauckneht M, Miceli A, Signori A, Albano D, Capitanio S, Piva R, Laudicella R, Franchini A, D\u2019Amico F, Riondato M, Chiola S, Marini C, Fornarini G, Scarale A, Muni A, Bertagna F, Burger IA, Sambuceti G, Morbelli S (2023) Combinedforced diuresis and late acquisitionon [. Clin practice-oriented Study EurRadiol 33(5):3343\u20133353","journal-title":"Clin practice-oriented Study EurRadiol"},{"issue":"3","key":"238_CR13","first-page":"469","volume":"59","author":"M Eiber","year":"2018","unstructured":"Eiber M, Herrmann K, Calais J, Hadaschik B, Giesel FL, Hartenbach M et al (2018) Prostate cancer molecular imaging standardized evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-ligand PET\/CT. J NuclMed 59(3):469\u2013478","journal-title":"J NuclMed"},{"issue":"5","key":"238_CR10","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1007\/s00259-022-06089-w","volume":"50","author":"WP Fendler","year":"2023","unstructured":"Fendler WP, Eiber M, Beheshti M, Bomanji J, Calais J, Ceci F, Cho SY, Fanti S, Giesel FL, Goffin K, Haberkorn U, Jacene H, Koo PJ, Kopka K, Krause BJ, Lindenberg L, Marcus C, Mottaghy FM, Oprea-Lager DE, Osborne JR, Piert M, Rowe SP, Sch\u00f6der H, Wan S, Wester HJ, Hope TA, Herrmann K (2023) PSMA PET\/CT: joint EANM procedure guideline\/SNMMI procedure standard for prostate cancer imaging 2.0. Eur J NuclMed Mol Imaging 50(5):1466\u20131486","journal-title":"Eur J NuclMed Mol Imaging"},{"key":"238_CR7","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/s00259-016-3573-4","volume":"44","author":"FL Giesel","year":"2017","unstructured":"Giesel FL, Hadaschik B, Cardinale J, Radtke J, Vinsensia M, Lehnert W et al (2017) F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients. Eur J Nucl Med Mol Imaging 44:678\u2013688","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"238_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13550-022-00938-3","volume":"12","author":"D Koehler","year":"2022","unstructured":"Koehler D, Sauer M, Karimzadeh A et al (2022) Evaluation of [. EJNMMI Res 12:66","journal-title":"EJNMMI Res"},{"issue":"4","key":"238_CR16","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.3390\/biomedicines11041052","volume":"11","author":"D Librizzi","year":"2023","unstructured":"Librizzi D, Eilsberger F, Ottenthaler S, Ebrahimifard A, Luster M, Yousefi BH (2023) Diagnostic impact of dual-time PET\/CT with. Biomedicines 11(4):1052","journal-title":"Biomedicines"},{"key":"238_CR9","first-page":"12","volume":"12","author":"J Morawitz","year":"2022","unstructured":"Morawitz J, Kirchner J, Hertelendy J et al (2022) Is there a diagnostic benefit of late-phase abdomino-pelvic PET\/CT after urination as part of whole-body. 68Ga-PSMA-11 PET\/CT Restaging Patients Biochem Recurrence Prostate cancer after Radical Prostatectomy? EJNMMI Res 12:12","journal-title":"68Ga-PSMA-11 PET\/CT Restaging Patients Biochem Recurrence Prostate cancer after Radical Prostatectomy? EJNMMI Res"},{"issue":"13","key":"238_CR2","first-page":"3674","volume":"27","author":"MJ Morris","year":"2021","unstructured":"Morris MJ, Rowe SP, Gorin MA, Saperstein L, Pouliot F, Josephson D, Wong JYC, Pantel AR, Cho SY, Gage KL, Piert M, Iagaru A, Pollard JH, Wong V, Jensen J, Lin T, Stambler N, Carroll PR, Siegel BA, CONDOR Study Group (2021) Diagnostic performance of. Results CONDOR Phase III Multicenter Study Clin Cancer Res 27(13):3674\u20133682","journal-title":"Results CONDOR Phase III Multicenter Study Clin Cancer Res"},{"key":"238_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s11307-016-0957-6","volume":"18","author":"SP Rowe","year":"2016","unstructured":"Rowe SP, Macura KJ, Mena E et al (2016) PSMA-based [. Mol Imaging Biol 18:411\u2013419","journal-title":"Mol Imaging Biol"},{"issue":"4","key":"238_CR12","first-page":"485","volume":"73","author":"SP Rowe","year":"2018","unstructured":"Rowe SP, Pienta KJ, Pomper MG, Gorin MA, PSMA-RADS, Version (2018) 1.0: a step towards standardizing the interpretation and Reportingof PSMA-targeted PET imaging studies. EurUrol 73(4):485\u2013487","journal-title":"EurUrol"},{"key":"238_CR14","first-page":"286","volume":"42","author":"S Schmuck","year":"2017","unstructured":"Schmuck S, Mamach M, Wilke F, von Klot CA, Henkenberens C, Thackeray JT, Sohns JM, Geworski L, Ross TL, Wester HJ et al (2017a) Multiple time-point. Value Early Dynamic Delayed Imaging Clin Nucl Med 42:286\u2013293","journal-title":"Value Early Dynamic Delayed Imaging Clin Nucl Med"},{"key":"238_CR17","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1007\/s00259-017-3669-5","volume":"44","author":"S Schmuck","year":"2017","unstructured":"Schmuck S, Nordlohne S, von Klot CA, Henkenberens C, Sohns JM, Christiansen H, Wester HJ, Ross TL, Bengel FM, Derlin T (2017b) Comparison of standard and delayed imaging to improve the detection rate of [. Eur J Nucl Med Mol Imaging 44:960\u2013968","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"238_CR3","first-page":"546","volume":"61","author":"H Song","year":"2020","unstructured":"Song H, Harrison C, Duan H, Guja K, Hatami N, Franc BL, Moradi F, Aparici CM, Davidzon GA, Iagaru A (2020) Prospective evaluation of. Focus Disease Localization Changes Manage J NuclMed 61(4):546\u2013551","journal-title":"Focus Disease Localization Changes Manage J NuclMed"},{"key":"238_CR1","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.19.02757","volume":"38","author":"EJ Trabulsi","year":"2020","unstructured":"Trabulsi EJ, Rumble RB, Jadvar H et al (2020) Optimum imaging strategies for advanced prostate cancer: ASCO Guideline. J Clin Oncol 38:1963\u20131996","journal-title":"J Clin Oncol"},{"issue":"11","key":"238_CR4","first-page":"1797","volume":"58","author":"M Wondergem","year":"2017","unstructured":"Wondergem M, van der Zant FM, Knol RJJ, Lazarenko SV, Pruim J, de Jong IJ (2017) F-DCFPyL PET\/CT in the detection of prostate Cancer at 60 and 120 minutes: detection rate, image quality, activity kinetics, and Biodistribution. J NuclMed 58(11):1797\u20131804","journal-title":"J NuclMed"}],"container-title":["EJNMMI Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41824-025-00238-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41824-025-00238-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41824-025-00238-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T23:02:54Z","timestamp":1738364574000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhi.springeropen.com\/articles\/10.1186\/s41824-025-00238-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["238"],"URL":"https:\/\/doi.org\/10.1186\/s41824-025-00238-8","relation":{},"ISSN":["3005-074X"],"issn-type":[{"value":"3005-074X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,1]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Board approval was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The scientific guarantor of this publication is Rosa Mar\u00eda \u00c1lvarez P\u00e9rez.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"Miriam Guerra G\u00f3mez has significant statistical expertise.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Informed consent was obtained from all patients in this study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"No subject subjects or cohort overlap reported.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}}],"article-number":"5"}}